The 20 Best Merkel Cell Carcinoma Doctors Near Me

Paul Nghiem is a Dermatologist practicing medicine in Seattle, Washington. Dr. Nghiem is rated as an Elite provider by MediFind in the treatment of Merkel Cell Carcinoma. He is also highly rated in 2 other conditions, according to our data. His clinical expertise encompasses Merkel Cell Carcinoma, Squamous Cell Skin Carcinoma, Eccrine Porocarcinoma, and Melanoma.

Kelly Paulson is a Hematologist and an Oncologist practicing medicine in Seattle, Washington. Dr. Paulson is rated as an Elite provider by MediFind in the treatment of Merkel Cell Carcinoma. She is also highly rated in 11 other conditions, according to our data. Her clinical expertise encompasses Merkel Cell Carcinoma, Neuroendocrine Tumor, Small Cell Lung Cancer (SCLC), and Colorectal Cancer. Dr. Paulson is currently accepting new patients.

Dr. Kelly Harms, MD, PhD, is a faculty member in the Department of Dermatology at the University of Michigan and the director of our Multi-disciplinary Cutaneous Oncology clinic. She provides patient care in our Cutaneous Surgery and Oncology clinical programs, including the Mohs surgery clinic and multidisciplinary melanoma and cutaneous oncology clinics located within the U-M Rogel Cancer Center. Dr. Harms is a board-certified dermatologist and ACGME Fellowship-trained Mohs Surgeon, with specialized training and expertise in treating high-risk skin cancer.Dr. Harms joined the Dermatology faculty in 2014, upon completing her ACGME procedural dermatology fellowship, with advanced training in melanoma and cutaneous surgery and oncology at the Rogel Cancer Center. Her clinical work is focused on Mohs surgery and associated reconstruction, as well as the complex management of patients seen within our Multidisciplinary Melanoma and Merkel Cell Programs.Dr. Harms received her medical degree from the University of Alabama School of Medicine and her Ph.D. degree from the Medical Scientist Training Program in the Department of Cell Biology at the University of Alabama at Birmingham. She completed her internship in the Department of Internal Medicine, University of Michigan Hospitals. She completed her dermatology residency, post-doctoral research training, and procedural dermatology fellowship in the Department of Dermatology, University of Michigan Medical School. Her clinical research is focused on skin cancer biology and epidemiology, and therapy. Dr. Harms is rated as an Elite provider by MediFind in the treatment of Merkel Cell Carcinoma. She is also highly rated in 8 other conditions, according to our data. Her clinical expertise encompasses Merkel Cell Carcinoma, Melanoma, Eccrine Porocarcinoma, and Basal Cell Skin Cancer. Dr. Harms is board certified in Dermatology and Micrographic Dermatologic Surgery.

Dr. Christopher Bichakjian is professor of dermatology and chair of the Department of Dermatology at the University of Michigan Medical School.Dr. Bichakjian is a foremost expert in the field of cutaneous surgery and oncology. He has a special interest in Merkel cell carcinoma and established one of the first multidisciplinary programs in the world for this rare skin cancer in 2006. He has presented over 100 national and international invited lectures and visiting professorships, and authored or co-authored nearly 90 peer-reviewed publications with a primary focus on cutaneous oncology.Dr. Bichakjian received his medical degree from Radboud University in The Netherlands. After relocating to the US, he completed residency in dermatology and fellowship in micrographic surgery and cutaneous oncology at Michigan Medicine. He subsequently practiced Mohs surgery in private practice and served as adjunct faculty at Weill Medical College at Cornell University in New York City.In 2004, Dr. Bichakjian was recruited back to Ann Arbor to join the faculty in the Department of Dermatology at Michigan Medicine. He served as director of the UM Multidisciplinary Merkel Cell Carcinoma Program for more than a decade (2006-2017), In addition, he served as chief of the Division of Cutaneous Surgery and Oncology and as director of the Multidisciplinary Melanoma Program in the Rogel Cancer Center from 2017-2020. Dr. Bichakjian is rated as an Elite provider by MediFind in the treatment of Merkel Cell Carcinoma. He is also highly rated in 10 other conditions, according to our data. His clinical expertise encompasses Merkel Cell Carcinoma, Basal Cell Skin Cancer, Melanoma, and Eccrine Porocarcinoma. Dr. Bichakjian is board certified in Dermatology and Micrographic Dermatologic Surgery.

Giorgos Karakousis is a General Surgeon practicing medicine in Philadelphia, Pennsylvania. Dr. Karakousis is rated as an Elite provider by MediFind in the treatment of Merkel Cell Carcinoma. He is also highly rated in 31 other conditions, according to our data. His clinical expertise encompasses Melanoma, Merkel Cell Carcinoma, Adult Soft Tissue Sarcoma, Lymphadenectomy, and Gastrectomy. Dr. Karakousis is board certified in Surgery, 2008. Dr. Karakousis is currently accepting new patients.

Dr. Lipson is an internationally-recognized skin cancer and immunotherapy specialist at Johns Hopkins. He received his medical degree in 2005 from the Mount Sinai School of Medicine in New York City, where he graduated with distinction in research. He completed his internship and residency in Internal Medicine at The Johns Hopkins Hospital, and completed a Medical Oncology fellowship at the Johns Hopkins Kimmel Cancer Center. Dr. Lipson leads cutting edge clinical trials for patients with melanoma and other skin cancers. As a member of the Johns Hopkins Melanoma and Cancer Immunology Programs, he focuses on evaluating novel therapies for patients with high-risk or advanced disease. Dr. Lipson’s publications include the first reports of organ transplant recipients treated with immune checkpoint inhibitors for advanced cancer, and the first description of kidney retransplantation performed after immunotherapy–related organ rejection. Based on his published work, Dr. Lipson initiated a clinical trial testing a novel combination of immune-based therapies for kidney transplant recipients with advanced selected cancers. Results from this trial - the first of its kind - were reported in 2022 at an international oncology meeting. Dr. Lipson is a leader in the clinical development of relatlimab, an antibody blocking the LAG-3 immune checkpoint. He leads a phase 2 trial testing combination immune checkpoint inhibitor therapy—including anti-LAG-3—for patients with advanced basal cell carcinoma. In June 2021, Dr. Lipson presented findings from the first phase 3 study establishing the LAG-3 pathway as the third immune checkpoint pathway in history, after CTLA-4 and PD-1, for which blockade has clinical benefit. This trial supported the FDA's approval of a new therapy for patients with advanced melanoma. In addition to his research activities, Dr. Lipson is an educator in the field of cancer immunotherapy. Many of his lectures focus on the management of immune-mediated drug toxicities associated with novel cancer drugs. Dr. Lipson conducts regular clinical practices in Baltimore, Maryland and at Sibley Memorial Hospital in Washington, D.C. as part of the multidisciplinary Melanoma Program at Johns Hopkins. Dr. Lipson is rated as an Elite provider by MediFind in the treatment of Merkel Cell Carcinoma. He is also highly rated in 10 other conditions, according to our data. His clinical expertise encompasses Melanoma, Merkel Cell Carcinoma, Metastatic Uveal Melanoma, Melanoma of the Eye, and Pancreaticoduodenectomy. Dr. Lipson is board certified in American Board Of Internal Medicine.

Melissa Burgess, MD, is an assistant professor at the University of Pittsburgh School of Medicine and a medical oncologist. She specializes in the treatment of soft tissue and bone sarcomas and Merkel cell carcinoma. Dr. Burgess is rated as an Elite provider by MediFind in the treatment of Merkel Cell Carcinoma. She is also highly rated in 42 other conditions, according to our data. Her clinical expertise encompasses Adult Soft Tissue Sarcoma, Liposarcoma, Merkel Cell Carcinoma, Chondrosarcoma, and Gamma Knife Radiosurgery. Dr. Burgess is board certified in American Board Of Internal Medicine. Dr. Burgess is currently accepting new patients.

Dr. William H. Sharfman is an associate professor of oncology and dermatology at the Johns Hopkins University School of Medicine. His areas of clinical expertise include cutaneous oncology, dermatology and immunotherapy. He helped create the well-established Melanoma Program at the Johns Hopkins Kimmel Cancer Center in 1994. Dr. Sharfman serves as the director of cutaneous oncology and clinical co-director for oncology at the Johns Hopkins Melanoma Program. He earned his M.D. from the University of Toledo College of Medicine. He completed his residency at Cleveland Clinic and performed a fellowship in hematology and oncology at Cleveland Clinic. Dr. Sharfman's research interests include novel therapies for high risk and advanced melanoma patients. Dr. Sharfman is rated as an Elite provider by MediFind in the treatment of Merkel Cell Carcinoma. He is also highly rated in 16 other conditions, according to our data. His clinical expertise encompasses Melanoma, Merkel Cell Carcinoma, Eccrine Porocarcinoma, and Familial Pancreatic Cancer. Dr. Sharfman is board certified in American Board Of Internal Medicine.

Dr. Siegrid Yu is a dermatologic surgeon who specializes in Mohs micrographic surgery (a precise technique for removing skin cancer while sparing healthy tissue) and surgical reconstruction for skin cancer. She also has expertise in laser surgery; rejuvenation of aging skin, including use of Botox injections and soft tissue fillers, and treatments for visible leg veins; and cosmetic treatment of Asian skin. In her research, Yu investigates Merkel cell carcinoma and other skin cancers as well as skin cancer in immunosuppressed patients. Her research honors include the Clinical Career Development Award in Dermatologic Surgery from the Dermatology Foundation. Yu earned her medical degree at the University of Washington. She completed a residency in internal medicine at Stanford Medicine, where she served as chief resident. She completed a residency in dermatology at UCSF, where she also was chief resident, and a fellowship in Mohs surgery and procedural dermatology at UCSF. Yu is a member of the American Society of Dermatologic Surgery (ASDS) and has received an ASDS Cutting Edge Research Grant. She also is a member of the American Academy of Dermatology, American College of Mohs Surgery and American Medical Association. She serves as director of UCSF’s fellowship program in procedural dermatology. Dr. Yu is rated as an Elite provider by MediFind in the treatment of Merkel Cell Carcinoma. She is also highly rated in 7 other conditions, according to our data. Her clinical expertise encompasses Merkel Cell Carcinoma, Basal Cell Skin Cancer, Squamous Cell Skin Carcinoma, and Head and Neck Squamous Cell Carcinoma (HNSCC). Dr. Yu is board certified in American Board Of Dermatology, Micrographic Dermatologic Surgery and American Board Of Dermatology, Dermatology. Dr. Yu is currently accepting new patients.

Ann Silk is an Oncologist practicing medicine in Boston, Massachusetts. Dr. Silk is rated as an Elite provider by MediFind in the treatment of Merkel Cell Carcinoma. She is also highly rated in 8 other conditions, according to our data. Her clinical expertise encompasses Merkel Cell Carcinoma, Melanoma, Eccrine Porocarcinoma, Neuroendocrine Tumor, and Tissue Biopsy.

Isaac Brownell is a Dermatologist practicing medicine in Bethesda, Maryland. Dr. Brownell is rated as an Elite provider by MediFind in the treatment of Merkel Cell Carcinoma. He is also highly rated in 3 other conditions, according to our data. His clinical expertise encompasses Merkel Cell Carcinoma, Muir-Torre Syndrome, Warts, and Sebaceous Adenoma.

Lisa Zaba is a Dermatologist practicing medicine in Palo Alto, California. She has been practicing medicine for over 17 years. Dr. Zaba is rated as an Elite provider by MediFind in the treatment of Merkel Cell Carcinoma. She is also highly rated in 12 other conditions, according to our data. Her clinical expertise encompasses Merkel Cell Carcinoma, Melanoma, Dermatomyositis, and DRESS Syndrome.

Tomoko Akaike is a Dermatologist practicing medicine in Seattle, Washington. Dr. Akaike is rated as an Elite provider by MediFind in the treatment of Merkel Cell Carcinoma. She is also highly rated in 1 other condition, according to our data. Her clinical expertise encompasses Merkel Cell Carcinoma.

Sunandana Chandra is a Hematologist and an Oncologist practicing medicine in Chicago, Illinois. She has been practicing medicine for over 18 years. Dr. Chandra is rated as an Elite provider by MediFind in the treatment of Merkel Cell Carcinoma. She is also highly rated in 8 other conditions, according to our data. Her clinical expertise encompasses Melanoma, Merkel Cell Carcinoma, Squamous Cell Skin Carcinoma, and Melanoma of the Eye. Dr. Chandra is board certified in American Board Of Internal Medicine - Medical Oncology (Certified).

Jeffrey Farma is a Surgical Oncologist practicing medicine in Philadelphia, Pennsylvania. Dr. Farma is rated as an Elite provider by MediFind in the treatment of Merkel Cell Carcinoma. He is also highly rated in 27 other conditions, according to our data. His clinical expertise encompasses Melanoma, Adult Soft Tissue Sarcoma, Merkel Cell Carcinoma, Gastrostomy, and Lymphadenectomy.

Manisha Thakuria is a Dermatologist practicing medicine in Boston, Massachusetts. Dr. Thakuria is rated as an Elite provider by MediFind in the treatment of Merkel Cell Carcinoma. She is also highly rated in 6 other conditions, according to our data. Her clinical expertise encompasses Merkel Cell Carcinoma, Actinic Keratosis, Warts, and Granuloma Annulare. Dr. Thakuria is board certified in Dermatology.

Sandra D'angelo is an Oncologist practicing medicine in New York, New York. Dr. D'angelo is rated as an Elite provider by MediFind in the treatment of Merkel Cell Carcinoma. She is also highly rated in 33 other conditions, according to our data. Her clinical expertise encompasses Synovial Sarcoma, Adult Soft Tissue Sarcoma, Liposarcoma, Merkel Cell Carcinoma, and Liver Embolization. Dr. D'angelo is currently accepting new patients.

Upendra Parvathaneni is a Radiation Oncologist practicing medicine in Seattle, Washington. Dr. Parvathaneni is rated as an Elite provider by MediFind in the treatment of Merkel Cell Carcinoma. He is also highly rated in 12 other conditions, according to our data. His clinical expertise encompasses Merkel Cell Carcinoma, Adenoid Cystic Carcinoma, Salivary Gland Tumors, Olfactory Neuroblastoma, and Gastrostomy.

Howard Kaufman is a General Surgeon practicing medicine in Boston, Massachusetts. Dr. Kaufman is rated as an Elite provider by MediFind in the treatment of Merkel Cell Carcinoma. He is also highly rated in 3 other conditions, according to our data. His clinical expertise encompasses Melanoma, Merkel Cell Carcinoma, Neuroendocrine Tumor, and Eccrine Porocarcinoma.

Vernon Sondak is a General Surgeon practicing medicine in Tampa, Florida. Dr. Sondak is rated as an Elite provider by MediFind in the treatment of Merkel Cell Carcinoma. He is also highly rated in 12 other conditions, according to our data. His clinical expertise encompasses Melanoma, Merkel Cell Carcinoma, Neuroendocrine Tumor, Adult Soft Tissue Sarcoma, and Lymphadenectomy. Dr. Sondak is currently accepting new patients.